Pfizer
Camila R. Fontes-Garfias, PhD, currently serves as Principal Scientist at Pfizer, beginning this role in March 2021 after transitioning from a Senior Scientist position. Prior experience includes a Postdoctoral Research Fellow and Graduate Student at The University of Texas Medical Branch from August 2015 to February 2021, and a tenure in the US Army from October 2002 to September 2011, where Camila held roles as a Recruiter - Staff Sergeant and Automated Logistical Sergeant. Camila's educational background features a PhD in Biochemistry from The University of Texas Medical Branch, as well as bachelor's degrees in Natural Science & Mathematics and Biochemistry and Molecular Biology from Thomas Edison State University and Houston Christian University, respectively, along with an associate degree from Central Texas College.
This person is not in any teams
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.